Skip to main content
Caplight Logo









Spimed-AI

Spimed-AI

Private
ParisHealthcare & Life Scienceshttps://www.spimed-ai.com/

Last Round

Grant

Jul 7, 2022

Total Funding Raised

$566,000

Company Overview

Spimed-AI is a medical diagnostics company that develops artificial intelligence-powered software for the automated detection and classification of coronary lesions from coronary CT angiography (CCTA) scans.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

coronary computed tomography angiographyCCTAfractional flow reserveFFRmedical imaging AIcardiac imagingdiagnostic softwarecoronary artery diseaseCAD-RADSradiology AIclinical decision supportmedical SaaSAI radiologycardiology softwareautomated lesion detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spimed-AI Comparables

Compare Spimed-AI with similar companies based on industry and business-model similarity.

Spimed-AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Caristo Diagnostics
81%
Artrya Ltd
80%
Cleerly
78%

Spimed-AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 7, 2022
AcceleratorJan 1, 2021

Key People

Founding team and executive leadership

JEAN-FRANCOIS PAUL

CEO and FOUNDER

Founding Team

Henri Giroussens

Chief Technology Officer, Data Scientist

Executive Team

Loïc Paul Venturine

COO, Directeur juridique

Executive Team

Spimed-AI Investors

Notable investors and investment history

Spimed-AI investors
InvestorRounds
Paris Biotech SantéAccelerator
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    Monthly visitors increased 90% MoM.

  • Feb 2, 2026

    Grew 35% QoQ, from 17 to 23 employees.

Spimed-AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spimed-AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spimed-AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range25
Year Founded2019
Last FundingJul 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?